...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: a $6 sell order drops ZEN 96% !

I think this is the direct result of a management team which has failed it shareholders since 2013 for not having us listed at a bare minimum on a Canadian exchange!!

Share
New Message
Please login to post a reply